Geko™ Cross Therapy Registry - Wound
Running, not enrolling
Conditions studied: Wound, Venous Leg Ulcer, Diabetic Foot Ulcer, Arterial Leg Ulcer
In brief
The geko™ Cross Therapy REGISTRY - Wound is a prospective, observational, anonymised data collection Registry with no experimental treatment that will fulfil an unmet need for an observational Registry to provide long-term clinical data to demonstrate patient benefit and regulatory compliance.
Key facts
- Study ID
- NCT05007301
- Run by
- Firstkind Ltd
- People needed
- 2500
- Starts
- 2022-04-04
- Expected to finish
- 2028-03-01
- Last updated by the study team
- 2024-03-01
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Aged ≥ 18 years
- Intact healthy skin at the site of geko™ device application.
- Willing and able to give written informed consent
- Presence of an ulcerative wound to the lower leg
- Identified to receive geko™ therapy as part of their standard care for wound management.
You may not qualify if…
- Pregnancy or breast feeding.
- Use of any other neuro-modulation device.
- Current use of TENS in the pelvic region, back or legs
- Trauma to the lower limbs that would prevent geko™ from stimulating the common peroneal nerve.
- No response to geko™ therapy i.e., no involuntary rhythmic upward and outward movement of the foot (dorsiflexion) at the maximum tolerable device setting
Where it is running
- Northwell Health System — New York, New York, United States
- Central London Community Health Care NHS Trust — London, United Kingdom
- Norfolk Community Health and Care NHS Trust — Norwich, United Kingdom
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.